GleamWall
中文EN

AVAI AVAI BIO, INC.

Services-Computer Processing & Data Preparation · OTC · SEC CIK 1740797 · Fiscal year ends 03/31

Financial factors as of 2026-09-30 (2027Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-3,582.8%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE—
ROA-239.1%
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets405.2%
Debt / equity—
Current ratio0.04x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.55x
Accruals ratio-107.6%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2027Q22026-09-302027Q12026-06-302026Q4*2026-03-312026Q32025-12-312026Q22025-09-302026Q12025-06-302025Q4*2025-03-312025Q32024-12-31
Income statement
Revenue————————
R&D expense——-$8,804$0$23,804———
SG&A expense$174,304$176,480$192,237$190,119$265,022$213,886-$175,003$259,974
Operating income-$253,240-$552,041-$255,177-$553,727-$453,016$487,589-$2.75M$452,298
Pretax income———————-$452,298
Net income-$253,240-$552,041-$255,177-$553,727-$453,016$487,589$464,072-$452,298
EBITDA-$244,632-$546,797-$248,659-$547,210-$446,499$494,107-$2.73M$471,815
EPS (basic)0.000.00—0.000.000.00—0.00
EPS (diluted)————————
Balance sheet
Cash & equivalents$121,948$83,586$23,145$50,402$91,995$10,062$81,053$3,070
Current assets$188,043$154,281$89,340$60,852$112,795$20,212$93,133$27,507
PP&E, net$1,500$1,500$1,500$1,500———$1,500
Intangibles$150,290$158,898$105,542$112,060$118,577$125,094$131,612$147,379
Total assets$1.12M$791,750$572,696$172,912$231,372$145,306$224,745$174,886
Current liabilities$4.53M$4.01M$3.39M$2.97M$2.53M$2.14M$1.79M$2.31M
Short-term debt——$24,918$124,590$124,590$30,000$30,000$30,000
Total liabilities$4.53M$4.01M$3.39M$2.97M$2.53M$2.14M$1.79M$2.31M
Shareholders' equity-$3.42M-$3.22M-$2.82M-$2.79M-$2.30M-$1.99M-$1.56M-$2.14M
Shares outstanding154.36M153.92M153.21M138.03M137.83M137.51M137.36M137.13M
Cash flow statement
Operating cash flow-$75,319-$414,258-$50,827-$347,127-$371,547-$240,343-$187,500-$134,353
Investing cash flow$0-$58,600——————
Financing cash flow$113,681$533,299$23,570$305,534$453,480$169,352$265,483$135,651
Depreciation & amortization$8,608$5,244$6,518$6,517$6,517$6,518$15,767$19,517

Free plan shows the latest 8 periods; Pro shows all 34 🔒

· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.